Are you listening, PhRMA?

  • by: |
  • 01/04/2010
Henry Waxman is at it again. The man despises pharmaceutical companies. It’s anybody’s guess as to why that is, but it likely has to do with the fact that the man hates the very concept of a profit-motive - and the pharmaceutical industry makes for an easy target these days.
 
Speaking to the Pacific Palisades Democratic Club this past weekend, Waxman said “The President and the Senate made very poor deals with PhRMA.”
 
He also declared, “I have said that I am not bound by that agreement.” And this isn’t the first time he has said that.
 
What does Waxman plan on telling President Obama during the reconciliation process for the health bills?
 
“I’m going to say, ‘Are we interested in protecting the profits of the drug companies or protecting seniors?’”
 
Okay. Are those two things mutually exclusive?
 
PhRMA is a target. The Obama Administration and Congressional leaders may need the industry for now, but once they get what they want the game is over.
 
We need no further proof of that than Senator Kent Conrad’s response to the public outrage caused by the Nebraska Medicaid deal. Conrad noted that “no Congress can bind a future Congress.”
 
Assuming the Nebraska Medicaid deal survives the conference committee, you can expect it will be rescinded in the near future. Just as we can expect Henry Waxman to continue his assault on the pharmaceutical industry.
 
Lesson of the day? If you play nice with a dog that’s always been mean, you just may get bitten.

CMPI

Center for Medicine in the Public Interest is a nonprofit, non-partisan organization promoting innovative solutions that advance medical progress, reduce health disparities, extend life and make health care more affordable, preventive and patient-centered. CMPI also provides the public, policymakers and the media a reliable source of independent scientific analysis on issues ranging from personalized medicine, food and drug safety, health care reform and comparative effectiveness.

Blog Roll

Alliance for Patient Access Alternative Health Practice
AHRP
Better Health
BigGovHealth
Biotech Blog
BrandweekNRX
CA Medicine man
Cafe Pharma
Campaign for Modern Medicines
Carlat Psychiatry Blog
Clinical Psychology and Psychiatry: A Closer Look
Conservative's Forum
Club For Growth
CNEhealth.org
Diabetes Mine
Disruptive Women
Doctors For Patient Care
Dr. Gov
Drug Channels
DTC Perspectives
eDrugSearch
Envisioning 2.0
EyeOnFDA
FDA Law Blog
Fierce Pharma
fightingdiseases.org
Fresh Air Fund
Furious Seasons
Gooznews
Gel Health News
Hands Off My Health
Health Business Blog
Health Care BS
Health Care for All
Healthy Skepticism
Hooked: Ethics, Medicine, and Pharma
Hugh Hewitt
IgniteBlog
In the Pipeline
In Vivo
Instapundit
Internet Drug News
Jaz'd Healthcare
Jaz'd Pharmaceutical Industry
Jim Edwards' NRx
Kaus Files
KevinMD
Laffer Health Care Report
Little Green Footballs
Med Buzz
Media Research Center
Medrants
More than Medicine
National Review
Neuroethics & Law
Newsbusters
Nurses For Reform
Nurses For Reform Blog
Opinion Journal
Orange Book
PAL
Peter Rost
Pharm Aid
Pharma Blog Review
Pharma Blogsphere
Pharma Marketing Blog
Pharmablogger
Pharmacology Corner
Pharmagossip
Pharmamotion
Pharmalot
Pharmaceutical Business Review
Piper Report
Polipundit
Powerline
Prescription for a Cure
Public Plan Facts
Quackwatch
Real Clear Politics
Remedyhealthcare
Shark Report
Shearlings Got Plowed
StateHouseCall.org
Taking Back America
Terra Sigillata
The Cycle
The Catalyst
The Lonely Conservative
TortsProf
Town Hall
Washington Monthly
World of DTC Marketing
WSJ Health Blog